Pfizer Inc is working with Chinese authorities to send its COVID-19 pill, Paxlovid, to the country that is dealing with a surge in COVID-19 cases, Chief Executive Officer Albert Bourla said in an interview with CNBC on Monday. In February 2022, China approved Paxlovid to treat high-risk patients in several provinces. The drug was supposed […]
The post Pfizer working to send COVID pill Paxlovid to China – CNBC appeared first on Inquirer News.
Disclaimer : We make no assurance about the completeness and accuracy of the content of this website. All news on this website is collected from various sources hence information may or may not be true. Money Nations does not verify the reliability of the content published. We do not accept any accountability for loss or damage occurred as a result of reliability on the content of this website.
Subscribe to our newsletters now and stay
up-to-date with new articles and exclusive offers.
Your email is safe with us. We won't spam.